What does VIVES Partners invest in?
VIVES Partners invests most often at Seed and Series A (57% of the rounds on record), in sectors such as Biotechnology, Health Care and Venture Capital & Private Equity.

Belgium · Investor
Last cheque observed Sep 2026; 8 cheques on record.
VC firmDeploying now
Follow VIVES Partners and see its new cheques in your feed. Start following
2 cheques in the last 12 months
Mostly Seed and Series A: 57% of its rounds
VIVES est un fonds d'investissement initié par l'UCLouvainFrom their own website
Every round we can evidence, newest first8 appearances
2 rounds
1 round
1 round
1 round
1 round
1 round
1 round
An announcement gives the size of the round, not the size of this investor's cheque: the only rounds that imply a cheque are those where they were the sole named investor.
From their own portfolio page (on their website)
VisibleAddtoany
Weaker than a round we watched, stronger than a list somebody sold us. A firm is far less willing to put a company on its own site that it never funded.
The investors most often in the same rounds as VIVES Partners. A count of rooms they were both in, not a relationship either has claimed.
The latest companies VIVES Partners put money into.
VIVES Partners invests most often at Seed and Series A (57% of the rounds on record), in sectors such as Biotechnology, Health Care and Venture Capital & Private Equity.
8 investments on record, 2 of them in the last 12 months. The most recent was in Sept 2026.
Its most recent investments on record: Novadip Biosciences (Undisclosed round, Sept 2026), Bionyra Pharma (Series A, Jun 2026) and Nuclidium (Series B, Jul 2025).
The median round it joins is $56M.
Rarely, if at all: none of its 8 investments on record names it as the lead.
Most of the companies it backs are in Belgium (43%), France (43%) and Switzerland (14%).
Yes: it is actively investing, with 2 investments in the last 12 months.
Most often Nivelinvest (3 rounds together), Iris Capital (2 rounds together) and New Science Venture (2 rounds together).
Find the investors who back rounds like yours, and keep every conversation on one fundraising board.
Built from the rounds we watched, its filings and its own website, refreshed every night. How we count · Report a correction · Is this your firm? Claim it